Respiratory failure & ventilation

The Impact of Delayed Transition From Noninvasive to Invasive Mechanical Ventilation on Hospital Mortality in Immunocompromised Patients With Sepsis*

Crit Care MedPublished Retrospective cohort study

Main finding · Hospital mortalityResult — go to the resultAdjusted hazard ratio 1.006 95% CI 0.959–1.055

Authors' conclusion

Prolonged NIV trial before delayed IMV transition is associated with higher mortality in immunocompromised sepsis patients ultimately intubated.

Study context

Population
Adult immunocompromised patients with sepsis requiring ventilation, 3530 hospitals across China, 2017–2019
Participants
36,187 participants · 3,530 hospitals
Exposure
Initial noninvasive ventilation (NIV) vs initial invasive mechanical ventilation (IMV)
Outcome
Hospital mortality
Methodological detailsnational claims data, multicentre, weighted Cox models
  • National claims data
  • Multicentre
  • Weighted Cox models

Main finding

As reported in the abstract

median 9-day follow-up

Adjusted hazard ratio

1.006

95% CI 0.959–1.055

NIV vs IMV
aHR 1.006 (95% CI 0.959–1.055)
Immediate transition to IMV (≤ 1 d) vs initial IMV, HR
1.65
Late transition to IMV (≥ 8 d) vs initial IMV, HR
2.51

Observational data: associations, not effects.

Further findings

OutcomeHR
Hospital mortality by time to IMV transition among NIV patientsImmediate vs IMV initiation1.65
Hospital mortality by time to IMV transition among NIV patientsLate vs IMV initiation2.51

Hospital mortality by time to IMV transition among NIV patients

Longer time to IMV transition associated with stepwise increases in mortality; dose-response persisted across subgroups and sensitivity analyses

Original publication

The Impact of Delayed Transition From Noninvasive to Invasive Mechanical Ventilation on Hospital Mortality in Immunocompromised Patients With Sepsis*. Crit Care Med. Published 21 August 2024. doi:10.1097/ccm.0000000000006400

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.